56 related articles for article (PubMed ID: 28576632)
1. The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents.
Zuniga ES; Korkegian A; Mullen S; Hembre EJ; Ornstein PL; Cortez G; Biswas K; Kumar N; Cramer J; Masquelin T; Hipskind PA; Odingo J; Parish T
Bioorg Med Chem; 2017 Aug; 25(15):3922-3946. PubMed ID: 28576632
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.
Moraski GC; Bristol R; Seeger N; Boshoff HI; Tsang PS; Miller MJ
ChemMedChem; 2017 Jul; 12(14):1108-1115. PubMed ID: 28654200
[TBL] [Abstract][Full Text] [Related]
3. Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects.
Abdelkhalek AS; Attia MS; Kamal MA
Curr Med Chem; 2024; 31(14):1896-1919. PubMed ID: 36852819
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.
Lee IY; Gruber TD; Samuels A; Yun M; Nam B; Kang M; Crowley K; Winterroth B; Boshoff HI; Barry CE
Bioorg Med Chem; 2013 Jan; 21(1):114-26. PubMed ID: 23211970
[TBL] [Abstract][Full Text] [Related]
5. NMI-SO
Babu A; Sunil K; Sajith AM; Reddy EK; Santra S; Zyryanov GV; Venkatesh T; Bhadrachari S; Nibin Joy M
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794119
[TBL] [Abstract][Full Text] [Related]
6. Mutations in MmpL3 alter membrane potential, hydrophobicity and antibiotic susceptibility in Mycobacterium smegmatis.
McNeil MB; Dennison D; Parish T
Microbiology (Reading); 2017 Jul; 163(7):1065-1070. PubMed ID: 28703701
[TBL] [Abstract][Full Text] [Related]
7. A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis
Patel N; O'Malley T; Zhang YK; Xia Y; Sunde B; Flint L; Korkegian A; Ioerger TR; Sacchettini J; Alley MRK; Parish T
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674058
[TBL] [Abstract][Full Text] [Related]
8. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.
Rodrigues Felix C; Gupta R; Geden S; Roberts J; Winder P; Pomponi SA; Diaz MC; Reed JK; Wright AE; Rohde KH
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607021
[TBL] [Abstract][Full Text] [Related]
9. Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.
Fernandes GFDS; Man Chin C; Dos Santos JL
Pharmaceuticals (Basel); 2017 Jun; 10(2):. PubMed ID: 28587160
[TBL] [Abstract][Full Text] [Related]
10. 3-Aryl-5-aminobiphenyl Substituted [1,2,4]triazolo[4,3-
Kopotilova AE; Moshkina TN; Nosova EV; Lipunova GN; Starnovskaya ES; Kopchuk DS; Kim GA; Gaviko VS; Slepukhin PA; Charushin VN
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838924
[TBL] [Abstract][Full Text] [Related]
11. Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury.
Spasov A; Ovchinnikova I; Fedorova O; Titova Y; Babkov D; Kosolapov V; Borisov A; Sokolova E; Klochkov V; Skripka M; Velikorodnaya Y; Smirnov A; Rusinov G; Charushin V
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677799
[TBL] [Abstract][Full Text] [Related]
12. Pyrimidines-Based Heterocyclic Compounds: Synthesis, Cytoxicity Evaluation and Molecular Docking.
El-Atawy MA; Alshaye NA; Elrubi N; Hamed EA; Omar AZ
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956864
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 3-(5-amino-1
Lim FPL; Tan LY; Tiekink ERT; Dolzhenko AV
RSC Adv; 2018 Jun; 8(40):22351-22360. PubMed ID: 35539716
[TBL] [Abstract][Full Text] [Related]
14. Novel camphor-based pyrimidine derivatives induced cancer cell death through a ROS-mediated mitochondrial apoptosis pathway.
Zhang Y; Wang Y; Zhao Y; Gu W; Zhu Y; Wang S
RSC Adv; 2019 Sep; 9(51):29711-29720. PubMed ID: 35531556
[TBL] [Abstract][Full Text] [Related]
15. Retracted Article: The synthesis and biological activity of marine alkaloid derivatives and analogues.
Zhou S; Huang G
RSC Adv; 2020 Aug; 10(53):31909-31935. PubMed ID: 35518151
[TBL] [Abstract][Full Text] [Related]
16. Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis.
Shelton C; McNeil M; Allen R; Flint L; Russell D; Berube B; Korkegian A; Ovechkina Y; Parish T
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0204121. PubMed ID: 35262374
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Aromatization of 4,7-Dihydro-6-nitroazolo[1,5-a]pyrimidines: Synthetic Possibilities and Limitations, Mechanism of Destruction, and the Theoretical and Experimental Substantiation.
Lyapustin DN; Ulomsky EN; Balyakin IA; Shchepochkin AV; Rusinov VL; Chupakhin ON
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443304
[TBL] [Abstract][Full Text] [Related]
18. An insight on medicinal attributes of 1,2,4-triazoles.
Aggarwal R; Sumran G
Eur J Med Chem; 2020 Nov; 205():112652. PubMed ID: 32771798
[TBL] [Abstract][Full Text] [Related]
19. Integrated Target-Based and Phenotypic Screening Approaches for the Identification of Anti-Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA.
Ferguson L; Wells G; Bhakta S; Johnson J; Guzman J; Parish T; Prentice RA; Brucoli F
ChemMedChem; 2019 Oct; 14(19):1735-1741. PubMed ID: 31454170
[TBL] [Abstract][Full Text] [Related]
20. Anthranilic amide and imidazobenzothiadiazole compounds disrupt
Smith J; Wescott H; Early J; Mullen S; Guzman J; Odingo J; Lamar J; Parish T
Medchemcomm; 2019 Jun; 10(6):934-945. PubMed ID: 31303991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
